| Literature DB >> 15876357 |
Tomas Radivoyevitch1, Ossama B Kashlan, Barry S Cooperman.
Abstract
BACKGROUND: Recent data suggest that ribonucleotide reductase (RNR) exists not only as a heterodimer R12R22 of R12 and R22 homodimers, but also as tetramers R14R24 and hexamers R16R26. Recent data also suggest that ATP binds the R1 subunit at a previously undescribed hexamerization site, in addition to its binding to previously described dimerization and tetramerization sites. Thus, the current view is that R1 has four NDP substrate binding possibilities, four dimerization site binding possibilities (dATP, ATP, dGTP, or dTTP), two tetramerization site binding possibilities (dATP or ATP), and one hexamerization site binding possibility (ATP), in addition to possibilities of unbound site states. This large number of internal R1 states implies an even larger number of quaternary states. A mathematical model of RNR activity which explicitly represents the states of R1 currently exists, but it is complicated in several ways: (1) it includes up to six-fold nested sums; (2) it uses different mathematical structures under different substrate-modulator conditions; and (3) it requires root solutions of high order polynomials to determine R1 proportions in mono-, di-, tetra- and hexamer states and thus RNR activity as a function of modulator and total R1 concentrations.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15876357 PMCID: PMC1142302 DOI: 10.1186/1471-2091-6-8
Source DB: PubMed Journal: BMC Biochem ISSN: 1471-2091 Impact factor: 4.059
Figure 1Quaternary states of R1. Modulators of RNR activity listed in this figure bind R1 to create higher order quaternary states. Tetramers exist in an equilibrium between low activity states (see k4 in Table 1) and inactive states (kcat = 0). Adapted from Scheme 1 in [4,5].
Parameter estimates of the reductase models. Fits to data are as shown in Figure 2.
| substrate | KsdATP | KsATP | KsdTTP | KsdGTP | KidATP | KiATP | KaATP | k2 | k2dA | k2A | k2e | k4 | k6 |
| ADP | 2 | 200 | 2.4b | 0.5 | 1.25 | 300 | 2000d | 0.21 | 0.03 | 0.16 | |||
| GDP | 1 | 100 | 0.5 | 2 | 2 | 190 | 2400 | 0.28a | 0.04 | 0.19 | |||
| CDP | 2 | 70 | 1.55b | 2c | 1.5 | 600 | 1400 | 0.25a | 0.29a | 0.08 | 0.32 | ||
| UDP | 1 | 100 | 0.7b | 2c | 0.5 | 200 | 800 | 0.26 | 0.26 | 0.26a |
Binding constants in μM, rate constants in 1/s.
afixed values taken directly from table 5 of [5].
busing Eq. 10, these were adjusted to yield fluxes of 12.5, 12.5, 20 and 5 (uM/min) for ADP, GDP, CDP and UDP, respectively, under assumptions of E0 = 16 μM, ADP = 430 μM, GDP = 110 μM, CDP = 55 μM, UDP = 170 μM, KmADP = 12 μM, KmGDP = 4.9 μM, KmCDP = 2 μM, KmUDP = 6.4 μM, ATP = 1450 μM, dATP = 10.5 μM, dGTP = 7.3 μM, dTTP = 30 μM and the remaining parameter values in Table 1, see [7].
cno data, thus, these can be assumed to have any value between .5 and 2; a default value of 2 was carried down from GDP.
dno data, 2000 is based on the other rows.
Figure 2Data from [4-6] and corresponding curve fits (Table 1) of the RNR activity models. In these plots, from left to right, for ADP reduction dGTP was 2.1 uM or variable, for GDP reduction dTTP was 100 uM, 300 uM, variable, or 85 uM, and for pyrimidines specificity site binding concentrations were as shown. In all cases NDP and R2 were at saturating levels.
Figure 3GDP reductase as a function of ATP concentration at various R1 concentrations, predicted using the earlier model [3-6].